“Solifenacin in Overactive Bladder Syndrome: Pharmacoeconomic Analysis”. 2008. Farmeconomia. Health Economics and Therapeutic Pathways 9 (1): 5-14. https://doi.org/10.7175/fe.v9i1.210.